Log in
Log in
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Barclays PLC
  6. News
  7. Summary
    BARC   GB0031348658


Real-time Estimate Cboe Europe  -  07:27 2022-11-28 am EST
160.69 GBX   +1.02%
07:08aLONDON MARKET MIDDAY: Global equities shaken by civil unrest in China
06:10aAnalyst recommendations: Jet2, Live Nation, Tyson, Twilio...
05:58aBarclays CEO To Work From Home After Starting Cancer Treatment
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Barclays Announces an Update on Over-Issuance Under the Barclays Bank PLC U.S. Shelf

09/30/2022 | 01:15pm EST

The U.S. Securities and Exchange Commission (“SEC”) has announced the resolution of its investigation of Barclays PLC (“BPLC”) and Barclays Bank PLC (“BBPLC”) relating to the over-issuance of securities by BBPLC under certain of its U.S. shelf registration statements. Pursuant to the terms of the resolution and as reflected in BPLC’s and BBPLC’s H122 Results Announcements, BPLC and BBPLC will pay a combined penalty of U.S.$200 million, without admitting or denying the SEC’s findings. The SEC has confirmed that BBPLC’s independent rescission offer to noteholders satisfies its requirements for disgorgement and related prejudgment interest.

Financial impact of the over-issuance

Further to the announcement on 15 September 2022 concerning the expiration of the rescission offer, Barclays confirms that the net cumulative attributable loss after tax in relation to the over-issuance of securities in the U.S. is expected to remain materially in line with the financial impact disclosed in BPLC’s and BBPLC’s H122 Results. Further details will be provided as part of BPLC’s Q322 Results Announcement to be published on or about 26 October 2022, including the extent to which changes in market prices of affected securities have resulted in a reduction in costs associated with the rescission offer, offset by a corresponding reduction in income associated with hedging arrangements.

Review led by external counsel

The previously announced review of the facts and circumstances relating to the over-issuance and the control environment related to such issuances led by external counsel (“Review”) is now complete. The over-issuance occurred because Barclays did not put in place a mechanism to track issuances after BBPLC became subject to a limit on issuance. Among the principal causes of the over-issuance were, first, the failure to identify and escalate to senior executives the consequences of the loss of well-known issuer status and, secondly, a decentralised ownership structure for securities issuances.

The Review further concluded that the occurrence of the over-issuance was not the result of a general lack of attention to controls by Barclays, and that Barclays’ management has consistently emphasised the importance of maintaining effective controls.

The Review’s findings will be used to consider individual accountabilities in relation to this matter and may include adjustments to remuneration, including to past variable remuneration, the potential for disciplinary action and performance management as appropriate.

Note: The BPLC and BBPLC H122 Results referred to above include further disclosures in relation to the over-issuance of securities.

About Barclays

Barclays is a British universal bank. We are diversified by business, by different types of customer and client, and geography. Our businesses include consumer banking and payments operations around the world, as well as a top-tier, full service, global corporate and investment bank, all of which are supported by our service company which provides technology, operations and functional services across the Barclays Group. For further information about Barclays, please visit our website home.barclays.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of Section 21E of the U.S. Securities Exchange Act of 1934, as amended, and Section 27A of the U.S. Securities Act of 1933, as amended, with respect to BPLC, BBPLC and the Group. Barclays cautions readers that no forward-looking statement is a guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’, ‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. These statements are based on the current beliefs and expectations of Barclays’ management and are subject to significant risks and uncertainties. Actual outcomes may differ materially from those expressed in the forward-looking statements. Factors that could impact Barclays’ future financial condition and performance are identified in BPLC’s and BBPLC’s respective filings with the SEC (including, without limitation, BPLC’s and BBPLC’s respective Annual Report on Form 20-F for the financial year ended 31 December 2021, as amended, and Interim Results Announcement for the six months ended 30 June 2022), which are available on the SEC’s website at www.sec.gov.

Subject to Barclays’ obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the U.S.), in relation to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

ę Business Wire 2022
All news about BARCLAYS PLC
07:08aLONDON MARKET MIDDAY: Global equities shaken by civil unrest in Chi..
06:10aAnalyst recommendations: Jet2, Live Nation, Tyson, Twilio...
05:58aBarclays CEO To Work From Home After Starting Cancer Treatment
05:36aBarclays CEO reveals cancer treatment but will continue to manage bank
04:56aBarclays CEO Venkat to undergo cancer treatment, prognosis 'excellent'
04:55aBarclays says CEO to undergo cancer treatment and to work from home
04:53aBarclays CEO CS Venkatakrishnan Diagnosed with Non-Hodgkin Lymphoma
04:46aLONDON BROKER RATINGS: UBS cuts Persimmon to 'sell' from 'neutral'
02:51aNESTLE : Barclays gives a Buy rating
02:40aTHYSSENKRUPP : Gets a Sell rating from Barclays
More news
Analyst Recommendations on BARCLAYS PLC
More recommendations
Sales 2022 25 059 M 30 290 M 30 290 M
Net income 2022 4 978 M 6 017 M 6 017 M
Net Debt 2022 - - -
P/E ratio 2022 5,40x
Yield 2022 4,55%
Capitalization 25 207 M 30 469 M 30 469 M
Capi. / Sales 2022 1,01x
Capi. / Sales 2023 0,97x
Nbr of Employees 81 600
Free-Float 99,7%
Duration : Period :
Barclays PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BARCLAYS PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 159,06 GBX
Average target price 230,83 GBX
Spread / Average Target 45,1%
EPS Revisions
Managers and Directors
C. S. Venkatakrishnan Group Chief Executive Officer & Director
Angela Anna Cross Group Finance Director & Executive Director
Nigel Paul Higgins Group Chairman
Mark Ashton Rigby Group Chief Operating Officer
Laura Padovani Global Head-Compliance Services
Sector and Competitors
1st jan.Capi. (M$)
BARCLAYS PLC-14.94%30 469
JPMORGAN CHASE & CO.-13.65%401 086
WELLS FARGO & COMPANY-1.13%180 770